In Alzheimer’s disease, neuroinflammation mediates the upregulation of the activated microglia (the pro-inflammatory M1 phenotype) with increased release of the pro-inflammatory factors, mainly interleukin-6 (IL-6). This evidence concerns the gene IL6 and early-onset autosomal dominant Alzheimer disease.